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We studied w hether Langerhans cell (LC)- and T-l ympho-
cyte fun ctions of atopic dermatitis (AD) patients are im-
paired. O ur stud y g roups consisted of 6 patients with AD 
with previous disseminated herpes simplex virus infection 
(AD + HSV), 8 patients with o rdinary AD, and 5 health y 
subj ects. Suction blisters were performed on abdominal 
skin and LC isolated on the basis of their attachment to 
IgG-coated erythrocy te monolayers. Antigen-presenting 
fun ction of purified LC was studied by measuring the pro-
liferation of HSV -stimulated T cells. Langerhans cells were 
also used to stimulate T cells in autol ogous mixed cell 
reaction (AM CR). In addition, the production of epidermal 
cell thymocyte-activating factor (ET AF) by crude epider-
mal cells was measured. 
D efective cell-medi ated immunity and overproduc-ti on of IgE are well-kno wn immunologic abno r-malities in ato pic derm atitis (AD) [1] . Impaired de-fense mechanisms render these patients susceptibl e to severe cutaneous bacterial, viral, and fun ga l in-
fecti ons. The underl ying cellular mechanisms in AD are at present 
fa r fro m clea r. T he main interest has been focused on abno rm al 
ly mphocyte fun ction, whereasthe role o f other immunologica ll y 
active cells like epidermal Langerhans cells (LC) has not been 
cla rified. Langerhans cells are a subgroup of dendrit ic cells [2] 
and fo rm a part of skin-associated lymphoid tiss ue [3]. T hey 
present antigens fo r T lymphocytes [4] and along w ith keratino-
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Abbreviat ions: 
AD: atopic derm atitis 
AD + HSV: ato pic dermat itis w ith cutaneous herpes simplex virus 
in fec tion 
AMCR: auto logous mixed cel l reaction 
EIA : enzy me immunoassay 
ET AF: epidermal cell thymocyte-acti va ting fac to r 
IL-1: interl cukin 1 
IL-2: interlcukin 2 
LC: Langerhans cell (s) 
PM A: 4,B-phorbol 12-m yristate 13-ace tate 
SI: stimulation index 
SRBC: sheep red blood cells 
T he HSV-induced T-cell proliferation in AD + HSV and 
AD patients was comparable with that of controls. T he 
AMCR responses of patients with AD + HSV and AD were 
clea rl y diminished w hen compared w ith healthy controls. 
Patients with AD also produced significantly less ET AF 
than controls. Our results sugges t that HSV anti gen-pre-
senting fun ction of LC from patients with AD + HSV seems 
to be intact. D efective AMCR may refl ect an abnormality 
in autoregulation and generation of effector cells and this 
together w ith decreased ET AF production may have path-
ogenetic significance in AD. ] In vest D ermato! 89: 15-18, 
1987 
cytes elaborate biologically active substances such as epidermal 
th ymocy te-acti va ting fac tor (ET AF) [5]. 
We studied whether LC- fun ction and T-cell fun ction are im-
paired in ordinary patients with AD and those with previous 
disseminated cutaneous herpes simplex vi rus infection (AD + H SV). 
Langerhans cells were used as accessory cells in H SV -induced 
proli fe ration of T -l ymphocytes and as stimulators in autologous 
mixed cell reaction (AM C R) . In addition, the ability of epiderm al 
cells to produce ET AF was compared in patient and healthy con-
trol groups. 
MATERIALS AND METHO D S 
Patients and Healthy Controls O ur study populatiOli con-
sisted of 5 hea lth y subjects, 8 o rdin ary patients with AD, and 6 
atopic patients w ith a history o f cutaneous herpes virus infections 
(T able I) . Within the las t year, 5 of the patients had had at least 
1 disseminated HSV -1 infection and 1 patient had suffered fro m 
HSV-l encephalitis and several local cutaneous herpes infections. 
Disseminated cutaneous infecti ons and encephalitis had been ver-
ified by isolation and typing and trea ted with acyclovir. A t the 
time of the stud y none of the patients had active herpes in fection . 
Enrichment of Epidermal LC T he purification procedu re of 
LC has been previously described in detail [6]. In brief, epidermal 
sheets were trea ted with 0.25% trypsin (G IBCO Ltd. , Paisley, 
Scotland) for 30 min at 37°C and then with 0.01 % DN ase I (Sigma 
C hemical Co., St. Louis, Missouri) fo r 5 min at roo m temper-
ature. T he sheets were pipetted vigorously and the cell suspension 
filtered th ro ugh a nylon mesh. The LC were isolated in tissue 
culture dishes by attaching them to sheep red blood cell (SRBC) 
monolayers coated with anti-SRBC IgG (Ca ppel Laborato ries 
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Table I. C haracteristi cs o f Patients With Ato pic D erm atitis and Contro ls 
Number and Ex tent Associated 
Subj ect Age Severity of Cutaneous HS V-I Atopi c Total IgE 
Number" (yea rs) of AD/' Infections Diseascs (IU/ ml) 
24 < 5 
2 40 19 
3 25 < 5 
4 20 17 
5 34 (, 
(, 29 Severe All ergic rhini tis 450 
7 20 Mild All ergic rhinitis 93 
8 30 Mild 7 
9 34 Mild Asthm a 3560 
10 20 Moderate 7 
11 49 Seve re 36900 
12 28 Severe Allergic rhinitis 3380 
13 35 Seve re Asthma 49')00 
14 31 Severe O ne disse minated Allergic rhinitis 3930 
15 19 Moderate O ne dissc minated, sevc ral loca l Asthm a 4420 
16 34 Moderate T wo dissemin ated 1(,20 
17 20 Mild O nc dissc minated, severa l local Asthm a, allcrgic rhinitis 336 
18 32 Moderate O nc disse minated, onc local l)2 
19' 31 Mild Several local Asthm a 147 
"Num bers 1-5 w ere hc:d thy co ntro ls . pati ents 6- 13 Iud o rd ill :t ry A D . alld p a ti l.: l1t s 14- 1<) h:ld previo us c ut :lI1 CO US hc rpl.' s in fecr io n (s) . 
/' Estil11 :HCd on the basis of an:tl11 llcsric and clinical da t:l . 
'T his pat ient had also had HSV-l enceph aliti s. 
Inc. , Cochranville, Penn sy lvani a). T o enh ance the binding o f LC 
to erythrocy te m ono layers the plates w ere centrifu ged ; this was 
fo ll owed by incubati on at 4°C. Lange rhans cell- enri ched cel ls 
were o btained after rem o val o f nonadherent cell s b y rockin g the 
pl ates and lysin g th e e ry throcy tes by hypo to ni c shock . The av-
erage purit y o f LC -enriched fracti ons was 80% as assessed b y 
staining o f O KT6-positi ve cell s . 
Separation of T Lymphocytes M ononucl ea r cell s were o b-
tained by Ficoll-Isopaque centrifugation of peripheral blood. These 
cell s w ere suspended in 10% hum an AB serum-HPMI 1640 :tIld 
in cubated in tissue culture di shes at 37°C fo r 1 h, after w hich 
no nadh erent cells were rem oved . N onadh erent ce ll s were trea ted 
w ith ca rbonyl iron fo r 1 h, follo wed b y depletio n o f phagocy ti c 
cells w ith a m agnet. The recovered ly mph ocy tes were rosetted 
tw ice w ith 2- aminoeth ylisothi ouronium bro mide-treated SHBC 
and centri fuged by Fi coll- Iso paq\l e. Contamin ating SRB C amon g 
T cell s w ere lysed b y hypotoni c shock. T-cell fractio ns contain ed 
> 95% T lymphocy tes (s tained by O KT 3), < 3% surface m em-
brane immunoglobulin-positi ve B lymphocytes, and < 0.2% 
m onocy tes as assessed by nonspecifi c es terase staining . 
Herpes Simplex Virus-Stimulated Cultures T cell s w ith o r 
w ithout 5% LC were suspended at a density of 0. 25· 10(' cells/ ml 
in RPMI 1640 containin g 10% auto logous plasm a. Vo lum es (0 .1 
m l) o f th ese suspensio ns we re pi petted per well o f V - bo tto m ed 
mi cro plates. Therea fter 0.1 m l o f va rious diluti ons of H SV-l and 
co rres po ndin g cont ro l ant igens (Behrin g w erke AG, Marburg, 
F.R .G .) w ere added per well. The cultures w ere termin ated after 
6 days of in cubati o n . Sixteen hours befo re harves tin g, 0 .125 JLC i 
o f 5-[ 12S I]iodo-2 ' - deoxy uridin e (Am ersham, Bucking hamshire, 
Eng land) containin g 1 JLM Au o rodeoxyuridin e was add ed to each 
w el l [71. The uptake of th e isoto pe was meas ured w ith a gamm a 
counter. 
Autologous Mixed Cell Reaction Cultures In th ese cultures . 
T lymphocy tes we re stimul ated w ith auto logous purifi ed LC. In 
preliminary ex perim ents it w as found th at o ptimum stimula to r 
to res ponder cell rati o w as 1: 1 and o ptimum culture tim e 7 da ys 
fo r bo th hea lth y controls and atopi c pati ents. Subsequentl y, 25,103 
T cell s were cultured in the presence o f 25·1U3 LC in V-bo tto m ed 
mi cro p lates fo r 7 da ys . In so m e ex perim ents exogenous inte rl eu-
kin I (I L-l , fin al concentratio n 10 units/ml , Genzy m e Corp . , 
N o rwa lk , Connecti cut), in te rlcukin 2 (IL-2, fin al concentratio n 
5%, Lymphocult-T-LF, Bio tes t, O ffenbach, F. R. C .), o r bo th 
were added to AM C R cul tures. At th e end o f the 7- day incubatio n 
perio d , pro liferati on o fT ce ll s was m eas ured as descri,bed above. 
Production and Measurement of ET AF Fo r the production 
o f ETAF crude epiderm al cell s (1 0(' cell s/ m l) w ere incubated in 
5% AS serum-RPM I in tiss ue culture tubes fo r 2 days. T o en-
hance th e elabo rati o n of ETAF, the culture m edium w as supple-
mented w ith 20 ng/ m l o f4{3-ph orboI1 2-myristate 13- acetate (PMA, 
Sig m a C hemi cal C o). The cell-free contro l tubes contained cu l-
ture m edium with PMA . 
Epiderm al cell th y m ocy te- acti vatin g fac to r acti vit y w as deter-
min ed as described b y Lu ge r et al \8], usin g th y m ocytes fro m 6-
to 8- week-o ld 13A LBe! A mice. Th y m ocy tes w ere suspended at 
a density o f1 5,10r. cells/ m l in RPMI supplem ented w ith 20% feta l 
ca lf se rum and 5.10 - 5 M 2-m ercap toe th ano l. One hundred mi-
crolite rs of thy m ocy te suspension , 50 iJ-l o f culture supern atants 
(di luted 1 :2-1 :8) o r purifi ed IL-l , and 50 iJ-I o fph ytohemagg lu-
tinin (4 iJ-g/ m l o f purified PHA , Well co m e, Dartfo rd , Eng land) 
were pi petted per well o fAat-b o tto m ed mi cro plates. Amounts of 
2.5 , 5, and 10 units/ml o f IL-l w ere used fo r determinati o n of 
standard slo pe. T he pl ates we re in cubated at 3rC fo r 3 day s and 
pro liferati o n o f the cel ls Ill easured as described above. The cpm 
va lue o f the undi luted sample was ca lculated o n the basis of th e 
diluti o n g iv ing 50% m ax imulll label in corpo rati o n . The results 
were read fro m th e stand ard s lo pe and ex pressed as units/ml. 
Other Meth ods T o tal IgE va lues were measured w ith a com-
m ercial nI ST kit (Pharmacia, Uppsa la, Sweden). The H SV- l 
antibo dies w ere m eas ured w ith an enzy m e immunoassay (E IA) 
as described previ ously \9\ . The HSV iso lates we re typed usin g 
a commercial immun oAu o rescence kit (Sy va Co., Palo Alto , C al-
ifo rni a). 
RESULTS 
T - Cell Proliferative Responses and Seru m Antibodies to 
HSV- l Ce ll-mediated imm unit y to H SV-l w as assessed in vitro 
by m easurin g the pro liferatio n of T lymphocytes stimulated w ith 
a comm ercial anti gen preparati o n . Accessory cell s were essenti al 
fo r T-cell b las t transfo rmati o n, and here we supplem ented th e 
cu ltures w ith 5% purified LC. T able II illus trates the resuits o f 
cell culture ex periments and serum antibody determin atio ns in 
individual cases . Three subj ects (numbers 5, 6, and 12) were 
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Table II. H crpcs Si mplex Virus (H SV)- I- Indu ccd Pro li feratio n ofT Lymph ocytcs, Scrum Antibod ics to HSV-I , Au to logous 
Mi xcd Ccll n.cac tions (AMRC) , and Gcnerat ion o f Epidcrm al T hymocyte-A ctivatin g Facto r (ETA F) in Paticnts With Atopi c 
Dcrmatitis and Hca lthy Contro ls 
H SV-I A ntibodies 
(l'IlZY lllc-ill l lnull o 
Subject Proli fe ra tion/. units) AM C R' ETAF 
NUI1lber" (S I) IgG IgM (S I) (U/ I11I ) 
49.5 70 0 14.4 II 
2 45.4 50 () 12.9 15 
3 IOJ) () 60 4.4 16 
4 12.0 0 <)0 10.2 26 
5 2.3 () 0 6.6 15 
6 1. 9 0 0 1.2 7 
7 36.<) 60 0 1.0 14 
8 32.0 50 0 3.7 10 
9 23.7 80 () 1. 6 8 
10 14.8 40 0 4.4 8 
II 62.8 <)0 0 1.3 4 
12 1.3 0 () 3.7 5 
13 20. 0 '60 0 2.9 8 
14 135.fl 30 0 4.2 4 
15 65.7 11 0 0 1.3 5 
16 180. () flO 0 5. 1 7 
17 50. 1 70 () 3.3 13 
I fl 4fl.2 50 0 1. 4 4 
19 59J, 140 70 0.6 3 
"Comro ls and pat icnts ill the same order as in T:lblc I. 
h2S-1 0J cdls/ wdl (Dill y T ce lls ill cOl1tro l cultu res :lII d T ce lls + 5 % L:l11gc rhalls cell s (LC) in :1 c ti vatcd cul("lJrcs) wcre in cuba ted in rhe presence of optimal amo unt of 
HSV- I an ti gens (d iluti o n I : 100 o f the s tock preparatio n). Stimu lat io n inel ex (S I) = m ea n Cp lll in cu ltures con tai nin g T cells. LC and H SV-lIlllean Cplll in cultures colltainin g 
T cells and I-I SV- 1. T he Cplll va lu es o f co ntro l cultures wne less than 100. M ock- infected control anti gen for HSV- I did no t indu ce proliferation . 
'25' 10' T lymphocytes we re cultu red alo ne (contro ls) o r s timu lated with 25' 10.1 LC. S I = pro lifera tio n of T ce ll s in t he presence ofstimubtor LC / prolifnatio n o f T cell s 
J lo nc. 
sero ncga tivc to HSV-l and th cy also showed no res po nse to th c 
antigen prcparation in the b last transfo rm Jtio n tcst (stimulat io n 
indices lcss than 3.0 we re considcrcd negativc) . Two subjccts (3 
and 4) had cvidcntl y had primary infcctio n, and th cir in vitro 
rcsponscs to HSV-l wc re relativcl y low. All seropositivc subjccts 
wcrc also positi vc in th e blast transform at ion test , but thcrc was 
no co rrela ti o n bctwccn antibody levcls and magnitudc of Iym-
phocy tc rcs po nsivencss. Sincc onl y 2 subjccts w ith pos iti vc H SV-
[gG antibodi cs wcrc includcd in o ur hea lth y co nt ro l g ro up, the 
rcsults o n HSV-l-indu ced prolifcratio n cannot be statistica ll y ana-
Iyzcd among diffcrcn t s tudy g roups. However, it seems that sc-
ropos iti ve atop ic patients w ith or w itho ut prcvio us disse min ated 
HSV-l in fect ion rcs pond w ell to herpcs antigcns in vitro. 
Autologous Mixed Cell Reaction and ET AF in Patient and 
Control Groups Langerh ans cclls, du e to th eir DR antigcn, are 
ablc to stimul ate auto logo us T lymphocy tes to pro li fcratc. Th is 
react ion was signifi ca ntl y impaircd (p < 0.0 1, Mann-Whitncy U 
tes t) in AD + H SV and AD g ro ups as comparcd with thc contro ls 
(2.7 ± 0.7 , 2.5 ± 0.5, and 9.7 ± 1.9, mca n stimulatio n indcx 
(S I) ± SEM , respcctivel y). T hc AM C R was ncga ti vc (S I < 3.0) 
in 3/6 AD + H SV paticnts and 5/8 AD paticnts but pos iti vc in all 
hca lth y subj ccts (Table II ). Dcfi cicnt AM C R did no t sec m to 
correlate w ith the severity of AD (Tables I, II ). 
Wc also measurcd ET AF ac ti vity in crude epidcrmal cell cul-
turcs (Ta ble II). Thc mean ± SE M va lucs in unitslml wcrc l6. 7 
± 2.5, 8.0 ± 1.1, and 6.0 ± 1.5 in healthy contro l, AD , and 
AD + HSV g roups, res pectivel y. Both AD and AD + HSV groups 
diffcred sig nifi cantly from thc contro ls (p < 0.0 1, Mann-Whitncy 
U test). The ETAF va lues did not co rrclatc with AMC n. o r ac-
tiv ity o f AD . Intcrcstingly, o ur paticnt w ith cnccphalitis had th e 
lowest ETAF and AMC R va lucs in spitc of good antibody levels 
and proliferativc responsivencss to HSV-l. 
[n AMC R, T cells bo th produ cc and res pond to IL-2 110]. 
[nterleukin 1 in turn promotes th c synthcsis of [L-2. We next 
studied w hether suppl ementat io n o f AM C R cultures w ith cx -
ogeno us I L-\ , I L-2, o r both rcstorcs dcfi cicnt proli fcration. With 
3 ato pic pati ents thc mca n AMC n. rcsponscs werc 2.6 (culturcs 
not suppl ementcd w ith interlcukins), 3 .4 (in the prescncc o f ex-
ogcnous IL-\ ), 5.5 (in thc presencc of IL-2), and 8. 1 (cu lture 
supplcmcnted w ith bo th IL-l and IL-2). In terleuk in 1 and IL-2 
toge thcr thu s ca used the most distin ct cnhanccmcnt of dcprcssed 
AM C n. . 
D [SCUSSIO N 
Hcre we prcscnt ev idcnce th at the in vitro T-I y mphocytc re-
spo nsivcncss o f H SV -l -scropositivc atopics to herpcs anti gcns is 
intact. Howcver, comparcd w ith thc hca lthy con tro l g ro up , pa-
ticnts w ith AD havc dcfects in ET AF productio n and A MCR . 
Ccll-mcd iatcd immunity to H SV was measurcd by T - Iym-
phocy tc pro li fc ration . In this systcm wc used cpidcrm al LC as 
antigcn-prcscnting ccll s. Wc and othcrs have prcvio usl y rcportcd 
that w ith scvera l antigcns LC are mo re cffccti vc acccssory cc ll s 
than arc mo nocytcs [11-13]. All seropositi vc subj ccts, w hether 
hca lthy o r atop ic, rcs ponded by blas t transformation to H SV. 
H owcver, thcre sec mcd to bc no co rrelatio n betvvccn se rum an-
tibody levels to HSV and m agnitud c of lym phocyte rcsponsc. 
We havc prcvio usly obta incd simil ar rcsults w ith mumps v irus 
11 4], and arc inclined to beli cve th at thcsc findin gs illustrate a real 
situatio n and arc no t du e to tcchni cal erro rs o r var iability. 
It is gcnerall y believed that ccll-mediated immunity is im pa ired 
in paticnts with AD and in crcascd susccptibility of these paticnts 
to di sseminatcd cu taneous vira l infections is onc m ani festation of 
defectivc immunity [1] . In vitro studies on cc ll-m cd iatcd im-
munity in paticnts w ith AD have g ivcn contradictory res ul ts. In 
many reports, anti gen-in d uced o r mitogcn-indu ccd T-lympho-
cy te pro li fe ratio n has been no rm al, w hereas other in vcstigato rs 
have obtaincd diminishcd rcsponses, espcciall y in scvere forms 
of AD li S]. It seems plausible that whcn lymphocytes arc acti-
vatcd with strong anti genic or mitogenic stimulants, subtle changes 
in their responsivcness cannot be dctcctcd . We believe that the 
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AMC R used in the present stud y is sui table for detectin g even 
sli g ht de fects in cellular interactio ns. 
In AM C R T lymphocy tes are act ivated by their ow n DR-
positi ve cells. Dendriti c cell s have been fou nd to be th e mos t 
potent autologous activa tors [1 6]. Autologous mi xed cell reaction 
has been observed to be impa ired in auto immune, immunop ro-
Iifera tive, and atopic diseases [1 0,17-19]. We are no t awa re of 
ea rlier reports in whi ch strongly DR-positive LC we re used as 
st imulator cell s in AM C R in atopic o r other diseases . In any case, 
o ur res ults resemble those o btained by o th ers with non- T cell s 
as auto logo us stimul ato rs [1 7-19]. In our hands, defec ti ve AMC R 
coul d be resto red by exogenous IL-1 and IL-2 . Impaired AMC R 
ma y thus reflect diminished produ ctio n o r res ponse of both in-
te rleu kins. Accord ing to newer concepts, AMC R represents an 
immune circui t th at leads to the activation of helper, cyto tox ic, 
and sup presso r T lymphocy tes 120]. Defective AM C R may be 
lin ked with dimini shed suppresso r and cytotoxic cell fun ction s 
observed earlier in AD [21-24]. T lymphocy tes reg ul ate IgE syn-
th es is, and ove rprod uction o f IgE in atopic diseases is believed 
to be due, at least in part, to defic ient suppresso r T-cell acti vity 
[25]. Further mo re, it has been specul ated w hether defective cy-
totoxic T-cell fun ctio n accounts fo r the increased susceptibility 
of patients with AD to v ira l in fect ions 12 1 I· 
It has recen tl y been ve rified that both LC and keratin ocy tes 
p rodu ce ETAF [5]. E piderm al cell thym ocy te-act iva tin g facto r is 
indi stin guishable from m onocyte-derived IL-1 and has a multi-
pli city of bio logic activities. It contributes to T-cell act iva ti on , 
possesses chemo tacti c activity for leukocy tes , medi ates fever, in-
du ces acu te-phase pro teins in the li ve r, and stimulates fibrob las t 
prolifera tio n 15]. Monocyte productio n o f IL-1 has been o bserved 
to be d iminished in patients with AD [26], but as far as wc know 
the im pa ired ca pacity of th eir epidermal cells to generate ETAF 
has not been described ea rlier . 
Some of o ur patients had had numero us loca l H SV infection 
episodes in addition to one or two dissemin ated ones in spite of 
the fac t that they developed secmin gly good hum o ral and cell-
med iated responses to this agen t . H erpes infectio ns tend to recur 
even in hea lth y individuals, but the infectio n susceptibility of 
patients w ith AD is clea rl y grea ter. The diminished capacity of 
these patients to prod uce biologica ll y ac ti ve m ediato rs such as 
ET A F, and th eir defective autoregu lation and generation of ef-
fector cell s may contribute to impaired defense. 
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